Your browser doesn't support javascript.
loading
Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients.
Coltro, Giacomo; Mangaonkar, Abhishek A; Lasho, Terra L; Finke, Christy M; Pophali, Prateek; Carr, Ryan; Gangat, Naseema; Binder, Moritz; Pardanani, Animesh; Fernandez-Zapico, Martin; Robertson, Keith D; Bosi, Alberto; Droin, Nathalie; Vannucchi, Alessandro M; Tefferi, Ayalew; Hunter, Anthony; Padron, Eric; Solary, Eric; Patnaik, Mrinal M.
Afiliação
  • Coltro G; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Mangaonkar AA; Haematology Unit, AOU Careggi, University of Florence, Florence, Italy.
  • Lasho TL; CRIMM, Centro di Ricerca e Innovazione per le Malattie Mieloproliferative, AOU Careggi, Florence, Italy.
  • Finke CM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Pophali P; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Carr R; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Gangat N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Binder M; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Pardanani A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Fernandez-Zapico M; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Robertson KD; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Bosi A; Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
  • Droin N; Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
  • Vannucchi AM; Haematology Unit, AOU Careggi, University of Florence, Florence, Italy.
  • Tefferi A; INSERM U1170, Gustave Roussy Cancer Center, 94805, Villejuif, France.
  • Hunter A; Faculté de Médecine, Université Paris-Sud, 94270, Le Kremlin-Bicêtre, France.
  • Padron E; INSERM US23, CNRS UMS 3655, AMMICa, Genomic platform, Gustave Roussy Cancer Center, 94805, Villejuif, France.
  • Solary E; CRIMM, Centro di Ricerca e Innovazione per le Malattie Mieloproliferative, AOU Careggi, Florence, Italy.
  • Patnaik MM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Leukemia ; 34(5): 1407-1421, 2020 05.
Article em En | MEDLINE | ID: mdl-31836856
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielomonocítica Crônica / Biomarcadores Tumorais / Regulação Leucêmica da Expressão Gênica / Proteínas Proto-Oncogênicas / Proteínas de Ligação a DNA / Mutação Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielomonocítica Crônica / Biomarcadores Tumorais / Regulação Leucêmica da Expressão Gênica / Proteínas Proto-Oncogênicas / Proteínas de Ligação a DNA / Mutação Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Ano de publicação: 2020 Tipo de documento: Article